top
Search terms
Results 1 - 10 of 21 - ordered by :
Pages: 1 2 3
Heart

Objectives To determine the accuracy of CHADS2 and CHA2DS2-VASc tools for predicting ischaemic stroke or transient ischaemic attack (TIA) and death in patients without a history of atrial ...

Heart, Coronary artery disease, L Brent Mitchell, Danielle A Southern, Diane Galbraith, William A Ghali, Merril Knudtson, Stephen B Wilton

Date : 01/10/2014
Heart

Keitaro Senoo, Gregory Y H Lip University of Birmingham, Centre for Cardiovascular Sciences, City Hospital, Birmingham, UK Correspondence to Professor Gregory Y H Lip, University of Birmingham, ...

Heart, Editorial, Keitaro Senoo, Gregory Y H Lip

Date : 01/10/2014
Eurointervention

EuroIntervention Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score Department for Coagulation Disorders, Skane ...

Date : 26/10/2012 Item size : 35329 bytes
Ehjournal

If a VKA is used, good quality anticoagulation control, defined as a time in therapeutic range (TTR) >70%, is crucial, given that the efficacy and (particularly) safety of VKA is intimately related ...

European Heart Journal, Editorial, Gregory Y.H. Lip, Deirdre A. Lane

Date : 07/12/2015 Item size : 179987 bytes
Epeuropace

When a clinician has to decide on use of antithrombotic drugs in the setting of a patient affected by atrial fibrillation (AF) experiencing an acute coronary syndrome (ACS), the difficult task is ...

Europace, Editorial, Giuseppe Boriani, Deirdre A. Lane, Stephan Windecker, Kurt Huber, Paulus Kirchhof, Gregory Y.H. Lip

Date : 01/09/2015
Ehjournal

Currently, the optimal combination of anticoagulants and anti-platelet therapy is unknown, but it is well established that the combination of regular doses and regimens as prescribed in AF or after ...

European Heart Journal, Moser, Martin, Olivier, Christoph B., Bode, Christoph

Date : 21/01/2014 Item size : 382265 bytes
Ehjournal

The current issue of the European Heart Journal focuses on a novel area of research, i.e. the function of microribonucloidacids (miRNAs). miRNAs are short, usually around 22-nucleotide-long ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/12/2014 Item size : 112207 bytes
Escardio

Miriam GOMEZ MOLINA (Abaran, Spain) 08:30 P175 Comparison of antithrombotic therapy and in-hospital outcomes after acute coronary syndrome in patients with and without atrial fibrillation Miriam ...

Poster Session 1: Non ST-elevation myocardial infarction - ACS

Date : 17/10/2015 Item size : 94783 bytes
Ehjournal

The current issue of the European Heart Journal focuses on a novel area of research, i.e. the function of microribonucloidacids (miRNAs). miRNAs are short, usually around 22-nucleotide-long ...

European Heart Journal, Lüscher, Thomas F.

Date : 01/12/2014 Item size : 136749 bytes
Ehjournal

Currently, the optimal combination of anticoagulants and anti-platelet therapy is unknown, but it is well established that the combination of regular doses and regimens as prescribed in AF or after ...

European Heart Journal, Moser, Martin, Olivier, Christoph B., Bode, Christoph

Date : 21/01/2014